bioRxiv Science⌕ Search

Biology subjects

Kim, T.-Y.

Publications and source records attributed to Kim, T.-Y..

2 recordsLinked to original sources

Cyclic-Phe-Pro Binds the ToxRS Interface to Promote Signal Transduction in Vibrio vulnificus

In Vibrio vulnificus, the quorum-sensing signal cyclo-(L-phenylalanine-L-proline) (cFP) binds the membrane receptor ToxRS to activate genes linked to oxidative-stress resistance and virulence. ToxR is a transmembrane transcription factor that pairs with ToxS to sense periplasmic signals, yet how V. vulnificus ToxRS recognizes cFP has remained undefined. AI-guided structure prediction revealed preferential ToxR/S heterodimer formation and a fold conserved with the V. cholerae crystal structure. Molecular docking placed cFP in a hydrophobic pocket at the ToxR-ToxS interface, where Phe279 stacked with its phenyl ring and Arg277 hydrogen-bonded its carbonyl oxygen. Introducing R277L and F279A substitutions lowered basal leuO expression and abolished cFP-dependent induction in a lacZ fusion assay. ChIP showed that cFP enhanced wild-type ToxR binding to the leuO promoter, whereas the mutant bound weakly and did not respond. Thus cFP bridges ToxR and ToxS to stabilize the heterodimer, facilitating ToxR recruitment to promoters and transcriptional activation in V. vulnificus.

biochemistry↗

SILAC-Based Quantitative Proteomics Identifies Multifactorial Mechanism of Oxaliplatin Resistance in Pancreatic Cancer Cells

Oxaliplatin is a commonly used chemotherapeutic drug for the treatment of pancreatic cancer. Understanding the cellular mechanisms of oxaliplatin resistance is important for developing new strategies to overcome drug resistance in pancreatic cancer. In this study, we performed a stable isotope labelling by amino acids in cell culture (SILAC)-based quantitative proteomic analysis of oxaliplatin-resistant and sensitive pancreatic cancer PANC-1 cells. We identified 107 proteins whose expression levels changed between oxaliplatin-resistant and sensitive cells, which were involved in multiple biological processes, including DNA repair, drug response, apoptotic signalling, and the type 1 interferon signalling pathway. Notably, myristoylated alanine-rich C-kinase substrate (MARCKS) and wntless homolog protein (WLS) were upregulated in oxaliplatin-resistant cells compared to sensitive cells, as confirmed by qRT-PCR and Western blot analysis. We further demonstrated the activation of AKT and {beta}-catenin signalling (downstream targets of MARCKS and WLS, respectively) in oxaliplatin-resistant PANC-1 cells. Additionally, we show that the siRNA-mediated suppression of both MARCKS and WLS enhanced oxaliplatin sensitivity in oxaliplatin-resistant PANC-1 cells. Taken together, our results provide insights into multiple mechanisms of oxaliplatin resistance in pancreatic cancer cells and reveal that MARCKS and WLS might be involved in the chemotherapeutic resistance in pancreatic cancer.

cancer biology↗